HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alain Prat Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Godart, F. Articles by Vincentelli, A. Search for Related Content PubMed Articles by Godart, F. Articles by Vincentelli, A. Related Collections Congenital - acyanotic Valve disease

J Thorac Cardiovasc Surg 2009;137:1141-1145
© 2009 The American Association for Thoracic Surgery

Congenital Heart Disease

Experimental off-pump transventricular pulmonary valve replacement using a self-expandable valved stent: A new approach for pulmonary incompetence after repaired tetralogy of Fallot?

^a Pôle de Cardiologie et Maladies Vasculaires, Centre Hospitalier Régional et Universitaire de Lille, Service des Maladies Cardiovasculaires Infantiles et Congénitales, Lille cedex, France
^b Pôle de Chirurgie Cardiovasculaire, Lille cedex, France
^c Pôle d'Hémato-Transfusion, Lille cedex, France
^d Université de Lille 2, EA 2693, Faculté de Médecine de Lille, Lille cedex, France

Received for publication March 30, 2008; revisions received June 9, 2008; accepted for publication July 5, 2008.

^_* Address for reprints: François Godart, MD, PhD, Pôle de Cardiologie et Maladies Vasculaires, Service des Maladies Cardiovasculaires Infantiles et Congénitales, Hôpital Cardiologique, CHRU de Lille, 59037 Lille cedex, France. (Email: f-godart{at}chru-lille.fr).

Objective: Off-pump valve replacement using self-expandable stents is an emerging technique for pulmonary valve disease. However, significant limitations are the lack of easily available valve substitute to be inserted within the stent and, in the setting of repaired tetralogy of Fallot, the existence of huge pulmonary trunk. We report the first experimental results of a transventricular approach using a decellularized porcine xenograft mounted in a self-expandable stent.

Methods: Pulmonary valve replacement was realized in 15 lambs by direct access of the infundibulum through a left thoracotomy, combined with pulmonary artery banding. Animals were followed by transthoracic echocardiography and, after control hemodynamic study, were electively killed either at day 7, month 1, or month 4 after implantation.

Results: Implantation succeeded in all lambs. Two animals died after implantation (1 pneumothorax and 1 endocarditis). Doppler echocardiographic follow-up did not show any significant transvalvular gradient and showed only mild pulmonary regurgitation. The hemodynamic control before termination revealed a systolic pulmonary valve gradient of 18.5 ± 12.4 mm Hg at 1 week (n = 4), 13.5 ± 10.6 mm Hg at 1 month (n = 4), and 4.3 ± 4.9 mm Hg at 4 months (n = 5). Gross examination demonstrated the presence of connective tissue between the valved stent and pulmonary wall, which increased with time.

Conclusion: Fifteen lambs underwent successful deployment of a self-expandable valved stent in the pulmonary position using a transventricular approach. This technique combined with pulmonary artery banding could be a therapeutic option for pulmonary insufficiency after repair of tetralogy of Fallot with a transannular patch.

This article has been cited by other articles:

				T. P. Graham Jr The Year in Congenital Heart Disease J. Am. Coll. Cardiol., January 12, 2010; 55(2): 147 - 155. [Full Text] [PDF]